Boothbay Fund Management »

CNS Pharmaceuticals shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of CNS Pharmaceuticals (CNSP) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in CNS Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including CNS Pharmaceuticals held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CNS Pharmaceuticals by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $71k 14k 5.25

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A Put Option (PLTR)
Abivax Sa Sponsored Ads (ABVX)
Alphabet Cap Stk Cl C Put Option (GOOG)
Mineralys Therapeutics Put Option (MLYS)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Apple (AAPL)

View all positions for Boothbay Fund Management

Top funds holding CNS Pharmaceuticals

Stonepine Capital Management
Ikarian Capital
DRW Holdings
Boothbay Fund Management
UBS Group
Barrett & Company
MAI Wealth Advisors
Danske Bank A/s

View all funds holding CNS Pharmaceuticals